Brain Cancer Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00024461
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 302
Buy Now

Brain Cancer Diagnostics Market Scope and Analysis by 2028

Buy Now

Brain Cancer Diagnostics Market Report Brain Cancer Diagnostics Market Size and Share Brain Cancer Diagnostics Market Scope and Analysis

Brain Cancer Diagnostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.64 Billion
Market Size by 2028 US$ 7.38 Billion
Global CAGR (2022 - 2028) 28.5%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Diagnostic Type
  • Imaging Test
  • Lumbar Puncture
  • Biopsy
  • Molecular Testing
  • Platform and Services
  • Cerebral Arteriogram
  • Neurological & Hearing Tests/Neurocognitive Assessments
  • Electroencephalography
By Cancer Type
  • Acoustic Neuroma
  • Astrocytomas
  • Craniopharyngiomas
  • Ganglioneuromas
  • Glioblastoma Multiforme
  • Meningiomas
  • Ependymomas
  • Oligodendroglioma
  • Low-Grade Tumors
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers & Research Institutes
By Tumor Size
  • 0.2 cm3 to 100 cm3
  • 101 cm3 to 200 cm3
  • Above 200 cm3
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC
  • Siemens Healthineers AG
  • GE Healthcare
  • MDxHealth
  • NantOmics
  • Biocept Inc
  • Koninklijke Philips N V
  • Canon Medical Systems
  • Hitachi Ltd

    • Company -Based Insights

    THERMO FISHER SCIENTIFIC INC; Siemens Healthineers AG; GE Healthcare; MDxHealth; NantOmics; Biocept, Inc.; Koninklijke Philips N.V.; Canon Medical Systems; Hitachi, Ltd.; Neusoft Medical Systems; KITZ HEIDELBERG; GENPATH; NVIDIA CORPORATION; ONCORA MEDICAL; BIOMIND; SOPHIA AND ONCODNA; Clinspec Diagnostics; Raindance Technologies, Inc; ROCHE DIAGNOSTICS; and Illumina, Inc are among the leading companies operating in the brain cancer diagnostics market